Announcement IL

FDA Warns Ozempic, Wegovy, and Other GLP-1 Drugs May Cause Permanent Vision Loss

Announcement from a bar association

Headline as published by Illinois Lawyer Now (ISBA) on Nov 12, 2026; collected by the wire Nov 12, 2026, 10:16 AM ET.

Read at Illinois Lawyer Now (ISBA)

The FDA warns Ozempic, Wegovy, and other GLP-1 drugs may cause permanent vision loss. It is requiring new safety warnings on the popular weight loss and diabetes medications after finding evidence of an increased risk of a serious eye condition that can cause blindness. The November 9, 2026, announcement affects medications including Ozempic, Wegovy, Mounjaro,... Continue Reading

From Illinois Lawyer Now (ISBA)’s feed

Coverage

  1. Illinois Lawyer Now (ISBA) Bar associations

    FDA Warns Ozempic, Wegovy, and Other GLP-1 Drugs May Cause Permanent Vision Loss

Named in this story

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method